Verdiva looks to challenge the dominance of Novo Nordisk and Eli Lilly, the makers of the two most popular weightloss drugs, Ozempic and Wegovy. The company promises to offer less invasive ...
Ozempic, approved for Type 2 diabetes, has gained fame for its weight-loss properties, especially among celebrities. Despite its rising popularity, ex ...